|
|
| HCN1_HUMAN |
HCN1 |
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1 |
8.393e-102 |
0.42
|
| RPA1_HUMAN |
POLR1A |
DNA-directed RNA polymerase I subunit RPA1 |
9.577e-89 |
0.33
|
| HCN4_HUMAN |
HCN4 |
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 |
2.154e-85 |
0.42
|
| MTR1C_XENLA |
mtnr1c |
Melatonin receptor type 1C |
1.353e-55 |
0.35
|
| HCN2_HUMAN |
HCN2 |
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 |
1.781e-48 |
0.39
|
| HCN3_HUMAN |
HCN3 |
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3 |
1.781e-48 |
0.39
|
| RXFP1_HUMAN |
RXFP1 |
Relaxin receptor 1 |
5.933e-46 |
0.39
|
| ADA1A_RABIT |
ADRA1A |
Alpha-1A adrenergic receptor |
7.638e-37 |
0.38
|
| G2YM83_BOTF4 |
|
Cytochrome b-c1 complex subunit Rieske, mitochondrial |
1.607e-30 |
0.44
|
| Q9TSW7_PIG |
ADRA1A |
Alpha-1A adrenergic receptor |
7.308e-29 |
0.30
|
| A4TVL0_9PROT |
|
Cereblon isoform 4 |
8.697e-28 |
0.34
|
| PDE10_RAT |
Pde10a |
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A |
8.39e-24 |
0.42
|
| MTR1A_HUMAN |
MTNR1A |
Melatonin receptor type 1A |
1.244e-23 |
0.42
|
| 5HT1A_MOUSE |
Htr1a |
5-hydroxytryptamine receptor 1A |
6.12e-22 |
0.34
|
| KCNK9_HUMAN |
KCNK9 |
Potassium channel subfamily K member 9 |
2.583e-19 |
0.39
|
| UHRF1_HUMAN |
UHRF1 |
E3 ubiquitin-protein ligase UHRF1 |
5.576e-19 |
0.30
|
| Q7ZJM1_9HIV1 |
pol |
Integrase |
2.402e-18 |
0.35
|
| MAP1_YEAST |
MAP1 |
Methionine aminopeptidase 1 |
3.703e-18 |
0.34
|
| MAP1_ECOLI |
map |
Methionine aminopeptidase |
3.944e-18 |
0.34
|
| DGAT1_MOUSE |
Dgat1 |
Diacylglycerol O-acyltransferase 1 |
5.655e-18 |
0.37
|
| CRBN_HUMAN |
CRBN |
Protein cereblon |
6.006e-18 |
0.34
|
| S13A5_HUMAN |
SLC13A5 |
Solute carrier family 13 member 5 |
8.486e-18 |
0.29
|
| UBC9_HUMAN |
UBE2I |
SUMO-conjugating enzyme UBC9 |
2.028e-17 |
0.32
|
| HRH1_CAVPO |
HRH1 |
Histamine H1 receptor |
4.532e-17 |
0.34
|
| MTR1B_HUMAN |
MTNR1B |
Melatonin receptor type 1B |
1.11e-16 |
0.36
|
| ADA1D_RAT |
Adra1d |
Alpha-1D adrenergic receptor |
3.331e-16 |
0.40
|
| DRD2_MOUSE |
Drd2 |
D(2) dopamine receptor |
8.882e-16 |
0.34
|
| 5HT3A_HUMAN |
HTR3A |
5-hydroxytryptamine receptor 3A |
2.442e-15 |
0.34
|
| HRH2_HUMAN |
HRH2 |
Histamine H2 receptor |
5.107e-15 |
0.34
|
| ADA1A_BOVIN |
ADRA1A |
Alpha-1A adrenergic receptor |
7.55e-15 |
0.40
|
| PPIA_HUMAN |
PPIA |
Peptidyl-prolyl cis-trans isomerase A |
4.041e-14 |
0.37
|
| CNR2_HUMAN |
CNR2 |
Cannabinoid receptor 2 |
4.385e-14 |
0.41
|
| Q95214_RABIT |
ACAT |
Acyl-CoA:cholesterol acyltransferase |
8.86e-14 |
0.35
|
| S12A2_HUMAN |
SLC12A2 |
Solute carrier family 12 member 2 |
2.224e-13 |
0.31
|
| E3UJZ5_SPOLI |
|
Ecdysone receptor |
3.251e-13 |
0.35
|
| BRPF1_HUMAN |
BRPF1 |
Peregrin |
1.394e-12 |
0.35
|
| 5HT3A_CAVPO |
HTR3A |
5-hydroxytryptamine receptor 3A |
1.649e-11 |
0.39
|
| AGTRA_RAT |
Agtr1 |
Type-1A angiotensin II receptor |
2.997e-11 |
0.30
|
| CCNB2_HUMAN |
CCNB2 |
G2/mitotic-specific cyclin-B2 |
4.216e-11 |
0.38
|
| CCNB3_HUMAN |
CCNB3 |
G2/mitotic-specific cyclin-B3 |
4.216e-11 |
0.38
|
| KCNA5_HUMAN |
KCNA5 |
Potassium voltage-gated channel subfamily A member 5 |
1.027e-10 |
0.38
|
| PDE4A_HUMAN |
PDE4A |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A |
1.696e-10 |
0.37
|
| LYAM3_HUMAN |
SELP |
P-selectin |
2.778e-10 |
0.32
|
| S12A5_HUMAN |
SLC12A5 |
Solute carrier family 12 member 5 |
5.347e-10 |
0.31
|
| SMS2_HUMAN |
SGMS2 |
Phosphatidylcholine:ceramide cholinephosphotransferase 2 |
8.973e-10 |
0.33
|
| DRD1_PIG |
DRD1 |
D(1A) dopamine receptor |
1.472e-09 |
0.30
|
| SCNAA_HUMAN |
SCN10A |
Sodium channel protein type 10 subunit alpha |
1.603e-09 |
0.33
|
| SPRE_HUMAN |
SPR |
Sepiapterin reductase |
3.069e-09 |
0.35
|
| ILVB_YEAST |
ILV2 |
Acetolactate synthase catalytic subunit, mitochondrial |
3.152e-09 |
0.29
|
| MDR1_HUMAN |
ABCB1 |
ATP-dependent translocase ABCB1 |
6.476e-09 |
0.32
|
| Q9BHT9_PLABE |
G6PD-6PGL |
Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase |
6.906e-09 |
0.35
|
| KPCB_HUMAN |
PRKCB |
Protein kinase C beta type |
2.025e-08 |
0.38
|
| TRPM5_HUMAN |
TRPM5 |
Transient receptor potential cation channel subfamily M member 5 |
3.467e-08 |
0.32
|
| CARM1_MOUSE |
Carm1 |
Histone-arginine methyltransferase CARM1 |
4.023e-08 |
0.32
|
| CNR1_HUMAN |
CNR1 |
Cannabinoid receptor 1 |
4.322e-08 |
0.41
|
| PANK1_HUMAN |
PANK1 |
Pantothenate kinase 1 |
4.424e-08 |
0.28
|
| 5HT1A_RAT |
Htr1a |
5-hydroxytryptamine receptor 1A |
6.049e-08 |
0.39
|
| OX1R_RAT |
Hcrtr1 |
Orexin receptor type 1 |
6.409e-08 |
0.31
|
| ENPP2_HUMAN |
ENPP2 |
Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 |
1.015e-07 |
0.31
|
| DRD3_HUMAN |
DRD3 |
D(3) dopamine receptor |
1.378e-07 |
0.39
|
| NMBR_HUMAN |
NMBR |
Neuromedin-B receptor |
1.441e-07 |
0.30
|
| DGAT1_HUMAN |
DGAT1 |
Diacylglycerol O-acyltransferase 1 |
1.729e-07 |
0.37
|
| NSMA_RAT |
Smpd2 |
Sphingomyelin phosphodiesterase 2 |
2.362e-07 |
0.29
|
| 5HT3A_RAT |
Htr3a |
5-hydroxytryptamine receptor 3A |
2.63e-07 |
0.29
|
| NAMPT_MOUSE |
Nampt |
Nicotinamide phosphoribosyltransferase |
2.807e-07 |
0.32
|
| ABCG2_HUMAN |
ABCG2 |
Broad substrate specificity ATP-binding cassette transporter ABCG2 |
4.297e-07 |
0.40
|
| DRD3_RAT |
Drd3 |
D(3) dopamine receptor |
1.032e-06 |
0.33
|
| HDAC3_HUMAN |
HDAC3 |
Histone deacetylase 3 |
1.078e-06 |
0.45
|
| KDM4E_HUMAN |
KDM4E |
Lysine-specific demethylase 4E |
1.193e-06 |
0.29
|
| ECR_BOMMO |
EcR |
Ecdysone receptor |
1.318e-06 |
0.35
|
| 5HT7R_HUMAN |
HTR7 |
5-hydroxytryptamine receptor 7 |
1.323e-06 |
0.41
|
| B2LA1_HUMAN |
BCL2A1 |
Bcl-2-related protein A1 |
1.364e-06 |
0.32
|
| DRD4_HUMAN |
DRD4 |
D(4) dopamine receptor |
1.54e-06 |
0.36
|
| CCNB1_HUMAN |
CCNB1 |
G2/mitotic-specific cyclin-B1 |
1.649e-06 |
0.38
|
| PD2R2_MOUSE |
Ptgdr2 |
Prostaglandin D2 receptor 2 |
1.841e-06 |
0.28
|
| SC6A5_HUMAN |
SLC6A5 |
Sodium- and chloride-dependent glycine transporter 2 |
2.37e-06 |
0.29
|
| TS1R1_HUMAN |
TAS1R1 |
Taste receptor type 1 member 1 |
2.488e-06 |
0.30
|
| SEPR_MOUSE |
Fap |
Prolyl endopeptidase FAP |
2.574e-06 |
0.29
|
| DRD2_HUMAN |
DRD2 |
D(2) dopamine receptor |
2.625e-06 |
0.38
|
| DRD2_RAT |
Drd2 |
D(2) dopamine receptor |
3.754e-06 |
0.35
|
| NQO2_HUMAN |
NQO2 |
Ribosyldihydronicotinamide dehydrogenase [quinone] |
3.936e-06 |
0.36
|
| TYRO3_HUMAN |
TYRO3 |
Tyrosine-protein kinase receptor TYRO3 |
3.957e-06 |
0.37
|
| PD2R2_HUMAN |
PTGDR2 |
Prostaglandin D2 receptor 2 |
4.822e-06 |
0.39
|
| 5HT2A_RAT |
Htr2a |
5-hydroxytryptamine receptor 2A |
5.742e-06 |
0.39
|
| Q76353_9HIV1 |
|
Integrase |
6.641e-06 |
0.38
|
| CP2J2_HUMAN |
CYP2J2 |
Cytochrome P450 2J2 |
7.112e-06 |
0.29
|
| KPCG_HUMAN |
PRKCG |
Protein kinase C gamma type |
7.481e-06 |
0.36
|
| CLTR1_CAVPO |
CYSLTR1 |
Cysteinyl leukotriene receptor 1 |
8.413e-06 |
0.33
|
| 5HT4R_RAT |
Htr4 |
5-hydroxytryptamine receptor 4 |
8.679e-06 |
0.32
|
| KCNA3_HUMAN |
KCNA3 |
Potassium voltage-gated channel subfamily A member 3 |
9.876e-06 |
0.38
|